Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

436 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
KEAP1 and TP53 Frame Genomic, Evolutionary, and Immunologic Subtypes of Lung Adenocarcinoma With Different Sensitivity to Immunotherapy.
Scalera S, Mazzotta M, Corleone G, Sperati F, Terrenato I, Krasniqi E, Pizzuti L, Barba M, Vici P, Gallo E, Buglioni S, Visca P, Pescarmona E, Marinelli D, De Nicola F, Ciuffreda L, Goeman F, Fanciulli M, Giusti R, Vecchione A, De Maria R, Cappuzzo F, Marchetti P, Ciliberto G, Maugeri-Saccà M. Scalera S, et al. Among authors: vecchione a. J Thorac Oncol. 2021 Dec;16(12):2065-2077. doi: 10.1016/j.jtho.2021.08.010. Epub 2021 Aug 25. J Thorac Oncol. 2021. PMID: 34450259 Free article.
Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes.
Mazzotta M, Filetti M, Occhipinti M, Marinelli D, Scalera S, Terrenato I, Sperati F, Pallocca M, Rizzo F, Gelibter A, Botticelli A, Scafetta G, Di Napoli A, Krasniqi E, Pizzuti L, Barba M, Carpano S, Vici P, Fanciulli M, De Nicola F, Ciuffreda L, Goeman F, De Maria R, Vecchione A, Giusti R, Ciliberto G, Marchetti P, Maugeri-Saccà M. Mazzotta M, et al. Among authors: vecchione a. J Immunother Cancer. 2020 Aug;8(2):e000946. doi: 10.1136/jitc-2020-000946. J Immunother Cancer. 2020. PMID: 32759236 Free PMC article.
H-Ras gene takes part to the host immune response to COVID-19.
Sciacchitano S, Sacconi A, De Vitis C, Blandino G, Piaggio G, Salvati V, Napoli C, Marchetti P, Taurelli BS, Coluzzi F, Rocco M, Vecchione A, Anibaldi P, Marcolongo A, Ciliberto G, Mancini R, Capalbo C. Sciacchitano S, et al. Among authors: vecchione a. Cell Death Discov. 2021 Jun 25;7(1):158. doi: 10.1038/s41420-021-00541-w. Cell Death Discov. 2021. PMID: 34226505 Free PMC article. Review.
Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance.
Fattore L, Cafaro G, Di Martile M, Campani V, Sacconi A, Liguoro D, Marra E, Bruschini S, Stoppoloni D, Cirombella R, De Nicola F, Pallocca M, Ruggiero CF, Castaldo V, Catizone A, Del Bufalo D, Viglietto G, Vecchione A, Blandino G, Aurisicchio L, Fanciulli M, Ascierto PA, De Rosa G, Mancini R, Ciliberto G. Fattore L, et al. Among authors: vecchione a. Oncogene. 2023 Jan;42(4):293-307. doi: 10.1038/s41388-022-02547-9. Epub 2022 Nov 23. Oncogene. 2023. PMID: 36418472 Free PMC article.
B4GALT1 as a New Biomarker of Idiopathic Pulmonary Fibrosis.
De Vitis C, D'Ascanio M, Sacconi A, Pizzirusso D, Salvati V, Mancini M, Scafetta G, Cirombella R, Ascenzi F, Bruschini S, Esposito A, Castelli S, Salvucci C, Teodonio L, Sposato B, Catizone A, Di Napoli A, Vecchione A, Ciliberto G, Sciacchitano S, Ricci A, Mancini R. De Vitis C, et al. Among authors: vecchione a. Int J Mol Sci. 2022 Nov 30;23(23):15040. doi: 10.3390/ijms232315040. Int J Mol Sci. 2022. PMID: 36499368 Free PMC article.
Quantitative analysis of CEA expression in colorectal adenocarcinoma and serum: lack of correlation.
Guadagni F, Roselli M, Cosimelli M, Spila A, Cavaliere F, Arcuri R, D'Alessandro R, Fracasso PL, Casale V, Vecchione A, Casciani CU, Greiner JW, Schlom J. Guadagni F, et al. Among authors: vecchione a. Int J Cancer. 1997 Sep 17;72(6):949-54. doi: 10.1002/(sici)1097-0215(19970917)72:6<949::aid-ijc5>3.0.co;2-p. Int J Cancer. 1997. PMID: 9378556 Free article.
The prevalence of p53 immunoreactivity in anal canal carcinoma.
Indinnimeo M, Cicchini C, Stazi A, Limiti MR, Giarnieri E, Ghini C, Vecchione A. Indinnimeo M, et al. Among authors: vecchione a. Oncol Rep. 1998 Nov-Dec;5(6):1455-7. doi: 10.3892/or.5.6.1455. Oncol Rep. 1998. PMID: 9769387
436 results